Loading...
Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report
INTRODUCTION: Imatinib, a tyrosine kinase inhibitor, is a major therapeutic option for the management of unresectable aggressive fibromatosis. Unfortunately, for most patients of low or very low average income countries, surgery often is the first treatment option. This is related to unavailability...
Na minha lista:
| Udgivet i: | J Med Case Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4307220/ https://ncbi.nlm.nih.gov/pubmed/25488584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-8-416 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|